# Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery

> **NCT05766891** · PHASE2,PHASE3 · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 225 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **BEHAVIORAL:** Group 1
- **BEHAVIORAL:** Group 2
- **BEHAVIORAL:** Group 3

## Key facts

- **NCT ID:** NCT05766891
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-12
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 225 (ESTIMATED)
- **Last updated:** 2026-03-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05766891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05766891, "Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05766891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*